At the time of the information referred to in paragraph 1, the Member State shall make available to the Agency all relevant scientific information that it has at its disposal and any assessment by the Member State.
Kui liikmesriik esitab lõikes 1 osutatud teavet, teeb ta ravimiametile kättesaadavaks kogu talle teadaoleva asjakohase teadusliku teabe ning kõik liikmesriigis tehtud hindamiste tulemused.